These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 604196)

  • 21. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 22. Circulating Clq binding complexes in inflammatory bowel diseases.
    Einstein E; Charland C; Thayer WR
    Digestion; 1979; 19(1):65-9. PubMed ID: 456771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.
    Bene L; Füst G; Fekete B; Kovács A; Horváth L; Prohászka Z; Miklós K; Pálos G; Daha M; Farkas H; Varga L
    Dig Dis Sci; 2003 Jun; 48(6):1186-92. PubMed ID: 12822883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clq metabolism in ulcerative colitis and Crohn's disease.
    Potter BJ; Hodgson HJ; Mee AS; Jewell DP
    Gut; 1979 Nov; 20(11):1012-9. PubMed ID: 527870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE; Elmgreen J; Teisner B; Svehag SE
    Acta Med Scand; 1988; 223(6):557-60. PubMed ID: 3389208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y; Vernier RL; Fish AJ; Michael AF
    Lab Invest; 1979 Apr; 40(4):474-80. PubMed ID: 372673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement and meningococcal infection.
    Greenwood BM; Onyewotu II; Whittle HC
    Br Med J; 1976 Apr; 1(6013):797-9. PubMed ID: 1260336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease.
    Soltis RD; Hasz D; Morris MJ; Wilson ID
    Gastroenterology; 1979 Jun; 76(6):1380-5. PubMed ID: 155547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haemolytic complement in peripheral lymph of normal men.
    Olszewski WL; Engeset A
    Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement components and activation in primary biliary cirrhosis.
    Lindgren S; Laurell AB; Eriksson S
    Hepatology; 1984; 4(1):9-14. PubMed ID: 6420306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement components and their activation products in pleural fluid.
    Salomaa ER; Viander M; Saaresranta T; Terho EO
    Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IgG, IgM, IgA, secretory IgA and the complement components C3, C4 and C9 in the large intestine in nonspecific ulcerative colitis and Crohn disease].
    Konovich EA; Kirkin BV; Khalif IL
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jan; (1):71-5. PubMed ID: 3564783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J; Berkowicz A; Sørensen H
    Acta Med Scand; 1983; 214(5):403-7. PubMed ID: 6660048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM; Vallota EH; West CD
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum complement profile in human nephritides.
    Khanijo V; Gulati PD; Saha K; Rizvi SN
    J Assoc Physicians India; 1978 Jan; 26(1):1-11. PubMed ID: 711658
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement activity in middle ear effusions.
    Bernstein JM; Schenkein HA; Genco RJ; Bartholomew WR
    Clin Exp Immunol; 1978 Aug; 33(2):340-6. PubMed ID: 102478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.